NPHS1 and focal segmental glomerulosclerosis: Thus, the therapeutic effect of enhanced levels of GM3 brought about by treatment with VPA in FSGS mice results from (i) maintenance of nephrin expression, and (ii) maintenance of integrin β1, which may be involved in podocyte adhesion (Fig. 5B).